These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38950019)

  • 21. Long-Term Taste and Smell Outcomes After COVID-19.
    Sharetts R; Moein ST; Khan R; Doty RL
    JAMA Netw Open; 2024 Apr; 7(4):e247818. PubMed ID: 38652477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced olfactory bulb volume accompanies olfactory dysfunction after mild SARS-CoV-2 infection.
    Petersen M; Becker B; Schell M; Mayer C; Naegele FL; Petersen E; Twerenbold R; Thomalla G; Cheng B; Betz C; Hoffmann AS
    Sci Rep; 2024 Jun; 14(1):13396. PubMed ID: 38862636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and Prognostic Factors Associated with Early Recovery of Olfactory Dysfunction in COVID-19 Patients.
    Kreesaeng P; Tangbumrungtham N; Rachapattayakhom R; Roongpuvapaht B; Tanjararak K
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):68S-75S. PubMed ID: 37743845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural trajectory of recovery of COVID-19 associated olfactory loss.
    Khan AM; Lee J; Rammaha T; Gupta S; Smith H; Kannampallil T; Farrell N; Kallogjeri D; Piccirillo JF
    Am J Otolaryngol; 2022; 43(5):103572. PubMed ID: 35969913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remote psychophysical testing of smell in patients with persistent olfactory dysfunction after COVID-19.
    Martončíková M; Doležal P; Fabianová K; Karhánek M; Gálik J; Raček A; Popovičová A; Račeková E
    Sci Rep; 2023 Aug; 13(1):14090. PubMed ID: 37640847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persisting chemosensory impairments in 366 healthcare workers following COVID-19: an 11-month follow-up.
    Bussiere N; Mei J; Levesque-Boissonneault C; Blais M; Carazo S; Gros-Louis F; Laforce R; De Serres G; Dupre N; Frasnelli J
    Chem Senses; 2022 Jan; 47():. PubMed ID: 35522081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study.
    De Luca P; Camaioni A; Marra P; Salzano G; Carriere G; Ricciardi L; Pucci R; Montemurro N; Brenner MJ; Di Stadio A
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Features of Parosmia Associated With COVID-19 Infection.
    Lerner DK; Garvey KL; Arrighi-Allisan AE; Filimonov A; Filip P; Shah J; Tweel B; Del Signore A; Schaberg M; Colley P; Govindaraj S; Iloreta AM
    Laryngoscope; 2022 Mar; 132(3):633-639. PubMed ID: 34870334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-reported olfactory and gustatory dysfunctions in COVID-19 patients: a 1-year follow-up study in Foggia district, Italy.
    Fortunato F; Martinelli D; Iannelli G; Milazzo M; Farina U; Di Matteo G; De Nittis R; Ascatigno L; Cassano M; Lopalco PL; Prato R
    BMC Infect Dis; 2022 Jan; 22(1):77. PubMed ID: 35065619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemosensory Dysfunctions Induced by COVID-19 Can Persist up to 7 Months: A Study of Over 700 Healthcare Workers.
    Bussière N; Mei J; Lévesque-Boissonneault C; Blais M; Carazo S; Gros-Louis F; De Serres G; Dupré N; Frasnelli J
    Chem Senses; 2021 Jan; 46():. PubMed ID: 34423831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Objective Sensory Testing Methods Reveal a Higher Prevalence of Olfactory Loss in COVID-19-Positive Patients Compared to Subjective Methods: A Systematic Review and Meta-Analysis.
    Hannum ME; Ramirez VA; Lipson SJ; Herriman RD; Toskala AK; Lin C; Joseph PV; Reed DR
    Chem Senses; 2020 Dec; 45(9):865-874. PubMed ID: 33245136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recovery from olfactory and gustatory dysfunction following COVID-19 acquired during Omicron BA.1 wave in Italy.
    Boscolo-Rizzo P; Tirelli G; Meloni P; Hopkins C; Lechien JR; Madeddu G; Bonini P; Gardenal N; Cancellieri E; Lazzarin C; Borsetto D; De Vito A; De Riu G; Vaira LA
    Am J Otolaryngol; 2023; 44(5):103944. PubMed ID: 37354725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-lasting olfactory dysfunction in COVID-19 patients.
    Prem B; Liu DT; Besser G; Sharma G; Dultinger LE; Hofer SV; Matiasczyk MM; Renner B; Mueller CA
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3485-3492. PubMed ID: 34757458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testing olfactory dysfunction in acute and recovered COVID-19 patients: a single center study in Italy.
    Pasquini J; Maremmani C; Salvadori S; Silani V; Ticozzi N
    Neurol Sci; 2021 Jun; 42(6):2183-2189. PubMed ID: 33768438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: a matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation.
    Boscolo-Rizzo P; Hummel T; Hopkins C; Dibattista M; Menini A; Spinato G; Fabbris C; Emanuelli E; D'Alessandro A; Marzolino R; Zanelli E; Cancellieri E; Cargnelutti K; Fadda S; Borsetto D; Vaira LA; Gardenal N; Polesel J; Tirelli G
    Rhinology; 2021 Dec; 59(6):517-527. PubMed ID: 34553706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic review of the literature, case series, and recommendations for clinical assessment and management.
    Lechner M; Chandrasekharan D; Jumani K; Liu J; Gane S; Lund VJ; Philpott C; Jayaraj S
    Rhinology; 2020 Aug; 58(4):394-399. PubMed ID: 32386285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of long-term olfactory dysfunction confirmed by olfactory testing after a community COVID-19 outbreak.
    Gudziol H; Kirschstein T; Pletz MW; Weis S; Guntinas-Lichius O; Bitter T;
    HNO; 2022 Mar; 70(3):224-231. PubMed ID: 34940903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olfactory Dysfunction in Healthcare Workers with COVID-19: Prevalence and Associated Factors.
    Imène K; Mohamed K; Amal G; Mohamed A; Asma C; Asma A; Wael K; Kalboussi H; Olfa EM; Walid N; Maher M; Nejib M
    Recent Adv Inflamm Allergy Drug Discov; 2024; 18(1):67-77. PubMed ID: 37867280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phantosmia May Predict Long-Term Measurable Olfactory Dysfunction After COVID-19.
    Leung JS; Cordano VP; Fuentes-López E; Lagos AE; García-Huidobro FG; Aliaga R; Díaz LA; García-Salum T; Salinas E; Toro A; Callejas CA; Riquelme A; Palmer JN; Medina RA; González G C
    Laryngoscope; 2022 Dec; 132(12):2445-2452. PubMed ID: 36149773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smell Status in Children Infected with SARS-CoV-2.
    Rusetsky Y; Meytel I; Mokoyan Z; Fisenko A; Babayan A; Malyavina U
    Laryngoscope; 2021 Aug; 131(8):E2475-E2480. PubMed ID: 33443298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.